Andrew Mooney

Background

About Andrew Mooney

Broughton is a global Contract Research Organisation (CRO) partnering with future-focused organisations to bring safe, high-quality products to market across the pharmaceutical, healthcare, and lifestyle sectors. Our expertise spans regulatory compliance, scientific consultancy, and analytical testing, supporting innovators in developing life-enhancing products.Our in-house laboratory testing facilities are GMP compliant and ISO/IEC 17025 accredited, ensuring the highest standards of quality, safety, and compliance. We are regularly inspected by the MHRA, FDA, and UKAS, reinforcing our commitment to excellence. Additionally, we hold a Schedule 1 Controlled Drugs Licence from the UK Home Office, enabling us to support clients in highly regulated markets with specialised testing and compliance services.We provide specialist regulatory and scientific expertise for next-generation nicotine products. Our regulatory experience includes PMTA (Premarket Tobacco Product Applications), EU Medicinal Product Applications (MAA), TPD/TRPR (Tobacco Products Directive/Tobacco and Related Products Regulation) compliance, and toxicology assessments to support safer product innovation.Our Mission: To help our clients deliver life-enhancing products to market.Our Vision: To improve quality of life.